Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Continental Home Healthcare -A Demographic Play -- Ignore unavailable to you. Want to Upgrade?

To: CIMA who wrote (24)	3/3/1999 7:51:00 PM
From: Edward W. Richmond	Read Replies (1) \| Respond to of 69

Even with the cheap warrants the revenue growth and the anticipated earnings per share(fully diluted) should be very credible. More on this topic later. Regards, Ed

To: CIMA who wrote (24)	3/3/1999 9:47:00 PM
From: Edward W. Richmond	Read Replies (1) \| Respond to of 69

If we look at the exercising of all outstanding paper, I think we should have 11,453,522 shares(fully diluted). The converting to stock would generate about an additional $400,000, I think. There will be some kind of return on this additional capital which should have a positive impact on the top and bottom lines. What I need, and am waiting not too patiently for, is the actual net earnings figure. This certainly will not be available in March. It is possible that during our wait for more news, I may get a little bottom feeding opportunity. Regards, Ed